title: Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!".
authors.affiliation: Faculty of Health, Aarhus University, and The Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
authors.forename: Peter
authors.initials: P
authors.lastname: Humaidan
authors.affiliation: Center for Reproductive Medicine, Universiteit Ziekenhuis Brussel, VUB, Brussels, Belgium.
authors.forename: Nikolaos P
authors.initials: NP
authors.lastname: Polyzos
mesh_terms: D006063:Chorionic Gonadotropin / Q000009:adverse effects / Q000627:therapeutic use*; D004624:Embryo Transfer; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005300:Fertility Agents, Female / Q000009:adverse effects / Q000627:therapeutic use*; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000378:metabolism; D006801:Humans; D007246:Infertility / Q000188:drug therapy* / Q000503:physiopathology; D054315:Oocyte Retrieval; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D010060:Ovulation / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods*; D011247:Pregnancy; D016896:Treatment Outcome
chemical_list: D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone